AS 3 1.1 g/100mL (Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Cit INJECTION, SOLUTION) 1.1 g/100mL

AS 3 1.1 g/100mL is an intravenous solution containing Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, and Sodium Phosphate. This formulation is designed for fluid and electrolyte replenishment, supporting hydration and metabolic needs. Ideal for medical settings requiring precise electrolyte balance.

Strength

1.1 g/100mL

Pack Size

30 BAG in 1 CASE (14537-966-20) / 200 mL in 1 BAG

Manufacturer / TM Owner

Terumo BCT Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AS 3 1.1 g/100mL is primarily used for intravenous fluid and electrolyte replacement. It helps maintain hydration and supports metabolic processes in patients who require fluid therapy. This solution is often used in medical settings to address fluid deficits or to provide nutritional support during certain medical procedures.

Side Effects

When administered intravenously, AS 3 1.1 g/100mL helps to replenish fluids and electrolytes in the body. This can support overall hydration and help maintain proper metabolic function. The solution is designed to be well-tolerated when used as directed by healthcare professionals.

Precautions & Warnings

AS 3 1.1 g/100mL should be handled with care and administered under medical supervision. It is important to follow proper aseptic techniques when preparing and administering the solution. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

AS 3 1.1 g/100mL may interact with other medications or treatments when administered intravenously. It is important to inform healthcare providers of all current medications and treatments before use. Additionally, interactions with other intravenous solutions or medications should be carefully monitored.

Frequently Asked Questions

AS 3 1.1 g/100mL is used for intravenous fluid and electrolyte replacement, supporting hydration and metabolic needs.

AS 3 1.1 g/100mL should be administered intravenously under medical supervision, following proper aseptic techniques.

The common effects include replenishing fluids and electrolytes, supporting hydration, and maintaining metabolic function.

Yes, it should be handled with care, administered under medical supervision, and proper aseptic techniques should be followed.

Yes, it may interact with other medications or treatments, so it is important to inform healthcare providers of all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.